CAPE TOWN - Phase 2 of the vaccination rollout is expected to begin in May until October, President Cyril Ramaphosa has announced.
The country’s Phase 1 vaccination programme, which involves inoculating health workers, began in February following the suspension of an earlier plan to use the Oxford-AstraZeneca vaccine.
Phase 1 is currently being implemented over three months from February to April 2021, to target over 1.5 million healthcare workers countrywide.
Over 250 000 health workers have received the Johnson & Johnson vaccine to date as part of an implementation study.
The final inoculation phase targeting 22 million of the adult population is scheduled from November 2021 to February 2022 for all other residents.
Although the government has faced criticism over the slow pace in rolling out of vaccines, Ramaphosa is adamant that they will meet their vaccination targets.
Here’s what you need to know about the Phase 2 rollout in South Africa:
How will the Phase 2 rollout work?
How many vaccines have been secured?
Ramaphosa said the Aspen manufacturing plant in the Eastern Cape, which will be involved in producing the Johnson & Johnson vaccines, can produce 300 million doses a year and has been committed to Africa.
The role of private sector
Ramaphosa also commended the private sector for their key supporting role in the national effort.
In order to achieve the desired outcomes, South Africa must vaccinate 250 000 to 300 000 people per day.
rudolph.nkgadima@africannewsagency.com